Literature DB >> 33546044

Contrast-enhanced ultrasonographic imaging of hepatic splenosis: A case report.

Xiaofei Zhong1, Lulu Yang1, Jiayan Huang1, Liping Deng2, Ling Nie3, Qiang Lu1.   

Abstract

RATIONALE: Hepatic splenosis or heterotopic auto-transplantation of spleen in the liver usually occurs after either spleen trauma or surgery. It is of great importance for the differential diagnosis of hepatic splenosis and other liver tumors because surgery is usually not needed if a diagnosis of splenosis is confirmed. PATIENT CONCERNS: Multiple hepatic masses were revealed by grayscale ultrasound in a 55-year-old man complaining of persistent colic in the upper abdomen after greasy food. DIAGNOSIS: Benign neoplasm with enlarged lymph node in the gastro-hepatic ligament was suspected by contrast enhanced US. The nature of the hepatic mass was undetermined by CECT.
INTERVENTIONS: The lesions were surgically removed. OUTCOMES: Multiple splenic tissue implants in the liver and peritoneum were confirmed by pathology after surgery. The patient recovered well and was followed up for more than 1 year without recurrence. LESSONS: Splenosis should be included in the differential diagnosis of focal liver lesion in patients with a history of spleen trauma or surgery. In spite of nonspecific findings on pre-contrast ultrasound, splenosis shows characteristic homogeneous hyperenhancement in arterial and portal phases, as well as prolonged hyperenhancement in the late phase for more than 5 minutes. Furthermore, the confidence of the diagnosis of splenosis may be enhanced by identifying multiple masses with similar enhancing patterns in other regions of the abdominal cavity.
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33546044      PMCID: PMC7837972          DOI: 10.1097/MD.0000000000024243

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  7 in total

1.  Contrast-enhanced low-mechanical-index ultrasonography in hepatic splenosis.

Authors:  Giovanna Ferraioli; Antonella Di Sarno; Carmine Coppola; Antonio Giorgio
Journal:  J Ultrasound Med       Date:  2006-01       Impact factor: 2.153

2.  Intrahepatic splenosis mimicking hepatic adenoma.

Authors:  D R Gruen; M J Gollub
Journal:  AJR Am J Roentgenol       Date:  1997-03       Impact factor: 3.959

Review 3.  From the archives of the AFIP: primary vascular neoplasms of the spleen: radiologic-pathologic correlation.

Authors:  Robert M Abbott; Angela D Levy; Nadine S Aguilera; Luis Gorospe; William M Thompson
Journal:  Radiographics       Date:  2004 Jul-Aug       Impact factor: 5.333

4.  Evidence for spleen-specific uptake of a microbubble contrast agent: a quantitative study in healthy volunteers.

Authors:  Adrian K P Lim; Nayna Patel; Robert J Eckersley; Simon D Taylor-Robinson; David O Cosgrove; Martin J K Blomley
Journal:  Radiology       Date:  2004-04-29       Impact factor: 11.105

5.  Extensive abdominal splenosis: imaging features.

Authors:  S Greschus; N Hackstein; M F Puille; T Discher; W S Rau
Journal:  Abdom Imaging       Date:  2003 Nov-Dec

6.  Characterization of Focal Liver Lesions Indistinctive on B Mode Ultrasound: Benefits of Contrast-Enhanced Ultrasound.

Authors:  Yi Dong; Feng Mao; Jiaying Cao; Peili Fan; Wen-Ping Wang
Journal:  Biomed Res Int       Date:  2017-04-11       Impact factor: 3.411

7.  Hepatic splenosis mimicking HCC in a patient with hepatitis C liver cirrhosis and mildly raised alpha feto protein; the important role of explorative laparoscopy.

Authors:  M Abu Hilal; A Harb; B Zeidan; B Steadman; J N Primrose; N W Pearce
Journal:  World J Surg Oncol       Date:  2009-01-05       Impact factor: 2.754

  7 in total
  1 in total

1.  Application of multimodal imaging in the diagnosis of intrahepatic splenosis: Two case reports and a literature review.

Authors:  Weimin Liu; Simin Chen; Jianning Chen; Ting Jiang; Li Quan; Sidong Xie
Journal:  BJR Case Rep       Date:  2022-01-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.